BCM
SZYM

BlueCrest Capital Management’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

BlueCrest Capital Management’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-280,481
Closed -$802K – 1019
2015
Q1 		$802K Hold
280,481
– – 0.04% 391
2014
Q4 		$724K Hold
280,481
– – 0.02% 412
2014
Q3 		$2.09M Buy
+280,481
New +$2.62M 0.08% 235

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

BlueCrest Capital Management's SZYM Position: Q2 2015 in Review

BlueCrest Capital Management sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2015, closing a stake of 280,481 shares — an estimated $802K sold.

BlueCrest Capital Management first reported a position in SZYM in Q3 2014 and held it in 3 quarters. The position peaked at $2.09M in Q3 2014. 100 funds tracked by Wall St. Rank hold SZYM as of Q2 2015.

  • BlueCrest Capital Management reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • BlueCrest Capital Management sold 280,481 SOLAZYME INC COM STK (DE) shares in Q2 2015, an estimated $802K.
  • BlueCrest Capital Management first reported a position in SOLAZYME INC COM STK (DE) in Q3 2014 and held it in 3 quarters.
  • BlueCrest Capital Management's SOLAZYME INC COM STK (DE) position peaked at $2.09M in Q3 2014.
  • 100 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2015.

Based on BlueCrest Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.